Home › Free Stock Grades › MNKD
MannKind Corporation (MNKD) Stock Grade
MNKD · Healthcare
A+
Market Cap
$1.7B
P/E Ratio
295.6
Revenue Growth (YoY)
+22.2%
Net Margin
1.7%
Return on Equity
—
Dividend Yield
None
About MannKind Corporation's fundamentals
MannKind Corporation, a biotechnology company with a $1.7B market cap, is experiencing solid revenue growth of 22.2% year-over-year, indicating expanding commercial traction. However, the company operates with a thin net margin of 1.7%, meaning it retains only a small portion of each revenue dollar as profit. The stock trades at a notably elevated P/E ratio of 295.6, reflecting significant investor expectations for future earnings growth, while the company currently pays no dividend and shows no positive return on equity, suggesting it is not yet generating sustainable profits on shareholder capital.